Breast cancer is an etiologically heterogeneous disease with marked geograp
hical variations. Joint consideration of the relationship between specific
molecular alterations and known or suspected epidemiologic risk factors for
this disease should help distinguish subgroups of women that are at elevat
ed risk of developing breast cancer. In this article, we present a comprehe
nsive literature review of the etiologic and prognostic roles of Her-2/neu
and P53 among women. In addition,we discuss the advantages and limitations
of using biomarkers in epidemiological studies. We conclude that more resea
rch is needed to understand the complex relationships between genetic alter
ations and etiologic risk factors for breast cancer.